Nobilis® RT+IBmulti+G+ND
Nobilis RT+IBmulti+G+ND contains immunogenic strains of Infectious Bronchitis, Turkey Rhinotracheitis, Infectious Bursal Disease and Newcastle Disease viruses inactivated with formalin or b-propiolactone and suspended in the aqueous phase of an oil adjuvant emulsion.
Presentation
Emulsion for injection (water-in-oil).
White to nearly white oily emulsion.
Active ingredients
Per dose of 0.5 ml:
ART strain But1#8544 : inducing ≥ 9.5 log2 ELISA units*
IBV strain M41(Massachusetts): inducing ≥ 5.5 log2 VN units*
IBV strain 249g (D274/D207): inducing ≥ 4.0 log2 VN units*
IBDV strain D78: inducing ≥ 14.5 log2 VN units*
NDV strain Clone 30: inducing ≥ 4.0 log2 HI units per 1/50th dose*
or containing ≥ 50 PD50 units
* serological response in chickens
Target species
Chickens (future breeders)
Indications for use
Active immunisation of breeder chickens for:
- reduction of infection and prevention of egg drop caused by the Massachusetts serotype of Infectious Bronchitis virus;
- reduction of egg drop and egg shell defects caused by the D274/D207 serotype of Infectious Bronchitis virus;
- reduction of infection caused by Newcastle Disease virus;
- prevention of respiratory signs and reduction of egg drop and egg shell defects related to Avian Rhinotracheitis virus;
- passive immunisation of the progeny of the vaccinated birds against Infectious Bursal Disease for at least the first four weeks of life.
Onset of immunity: 4 weeks after vaccination.
Duration of immunity: one laying period.
Withdrawal periods
Zero days
Packaging
500 ml (1000 doses) of vaccine in PET bottles.
Legal category
POM-V
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.
Product images are representations of packaging and may not accurately reflect the current packaging available in the GB marketplace.
Date of preparation: November 2025
